← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1076 | 1076 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3122 | 62295-3122-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8510 | 71266-8510-1 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1076 | 1076 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1505 | 5446-1505-01 | Methotrexate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6037 | 71285-6037-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6031 | 71285-6031-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-475 | 76154-475-15 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2364 | 72934-2364-3 | Niacinamide; Clobetasol Propionate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1076 | 1076 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1076 | 1076 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1076 | 1076 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5170 | 71266-5170-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1077 | 1077 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-950 | 71170-950-25 | Fentanyl 500mcg and Ropivacaine HCl 250mg added to 250mL Normal Saline | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1077 | 1077 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-5 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-1 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2422 | 72627-2422-1 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6038 | 71285-6038-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6032 | 71285-6032-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-476 | 76154-476-15 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2321 | 72934-2321-2 | Niacinamide; Dapsone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1077 | 1077 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1077 | 1077 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7011 | 71285-7011-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1077 | 1077 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5250 | 71266-5250-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1078 | 1078 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5424 | 26436-5424-1 | Sermorelin acetate 300mcg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1078 | 1078 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-020 | 71591-020-01 | Metronidazole | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1011 | 5446-1011-01 | Mitomycin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1078 | 1078 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-565 | 72833-565-30 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6036 | 71285-6036-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1078 | 1078 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1321 | 72934-1321-2 | Niacinamide; Dapsone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1078 | 1078 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9022 | 71266-9022-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-115 | 73177-115-03 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7011 | 72196-7011-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1078 | 1078 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-608 | 69194-608-01 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1079 | 1079 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-175 | 70092-175-46 | Lidocaine 1% Bicarb 10 ml syr PF | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1079 | 1079 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-017 | 71591-017-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-3 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1079 | 1079 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-8 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6037 | 71285-6037-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1079 | 1079 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1400 | 72934-1400-2 | Niacinamide; Ivermectin; Metronidazole | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1079 | 1079 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9031 | 71266-9031-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-115 | 73177-115-25 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7039 | 71285-7039-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1079 | 1079 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-602 | 81375-602-01 | Phenylephrine Hydrochloride; Lidocaine | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1080 | 1080 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-156 | 73198-156-10 | Lipo-Mino-Mix-C | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-008 | 71591-008-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-2 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-3 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6043 | 71285-6043-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5250 | 71266-5250-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7039 | 71285-7039-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1080 | 1080 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6008 | 72196-6008-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1080 | 1080 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1081 | 1081 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-156 | 73198-156-30 | Lipo-Mino-Mix-C | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole Benzoate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-010 | 80098-010-01 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6045 | 71285-6045-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2391 | 72934-2391-2 | Niacinamide; Lactic Acid | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1081 | 1081 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5170 | 71266-5170-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-165 | 82396-165-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6009 | 72196-6009-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1081 | 1081 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6360 | 71266-6360-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1082 | 1082 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5177 | 26436-5177-2 | Trimix 50/30/2 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole Benzoate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6038 | 71285-6038-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1341 | 72934-1341-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-166 | 82396-166-01 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1082 | 1082 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1082 | 1082 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9065 | 83826-9065-0 | Phenylephrine Hydrochloride; Tropicamide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1083 | 1083 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-009 | 71591-009-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-565 | 72833-565-30 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1311 | 72934-1311-2 | Niacinamide; Spironolactone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9010 | 71266-9010-2 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1083 | 1083 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6007 | 72196-6007-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1083 | 1083 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1084 | 1084 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0020 | 70168-0020-1 | Testo25mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-016 | 71591-016-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2500 | 72627-2500-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2318 | 72934-2318-2 | Niacinamide; Tazarotene | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-166 | 73177-166-25 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1084 | 1084 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5170 | 71266-5170-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1084 | 1084 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1085 | 1085 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-055 | 70713-055-01 | TESTOSTERONE C 200MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole Benzoate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2501 | 72627-2501-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2429 | 72934-2429-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9032 | 71266-9032-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1085 | 1085 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5250 | 71266-5250-1 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1085 | 1085 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride; Tropicamide | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1086 | 1086 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone HYDROCHLORIDE CADD | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Metronidazole Benzoate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5055 | 26436-5055-3 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2505 | 72627-2505-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5020 | 71266-5020-2 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2299 | 72934-2299-4 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-170 | 70092-170-05 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1086 | 1086 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1086 | 1086 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9076 | 83826-9076-5 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1087 | 1087 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2588 | 72934-2588-2 | Alixi | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-019 | 71591-019-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5194 | 26436-5194-3 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-3 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2506 | 72627-2506-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5020 | 71266-5020-1 | Norepinephrine Bitartrate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1304 | 72934-1304-2 | Niacinamide; Tretinoin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1087 | 1087 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6009 | 72196-6009-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1087 | 1087 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Potassium Chloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1088 | 1088 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Finasteride; Minoxidil; Tretinoin; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-018 | 71591-018-01 | Metronidazole Benzoate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-02 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-8 | Methylcobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1088 | 1088 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1088 | 1088 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2022-2 | valid | 0 | 2026-10-17 |